The University of Texas MD Anderson Cancer Center (MDACC) — Houston, Texas

The University of Texas MD Anderson Cancer Center (MDACC) is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

The University of Texas MD Anderson Cancer Center (MDACC) has participated in 1 clinical trials.

Therapeutic areas: B-Cell Malignancies.

Sponsors: TransThera Sciences (Nanjing), Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Texas MD Anderson Cancer Center (MDACC)?

The University of Texas MD Anderson Cancer Center (MDACC) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Texas MD Anderson Cancer Center (MDACC) conducted?

The University of Texas MD Anderson Cancer Center (MDACC) has 1 clinical trials on record. Their work covers B-Cell Malignancies.

Is The University of Texas MD Anderson Cancer Center (MDACC) accredited by Crixeo Health?

The University of Texas MD Anderson Cancer Center (MDACC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Texas MD Anderson Cancer Center (MDACC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.